ATE234829T1 - Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden - Google Patents
Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxydenInfo
- Publication number
- ATE234829T1 ATE234829T1 AT98962044T AT98962044T ATE234829T1 AT E234829 T1 ATE234829 T1 AT E234829T1 AT 98962044 T AT98962044 T AT 98962044T AT 98962044 T AT98962044 T AT 98962044T AT E234829 T1 ATE234829 T1 AT E234829T1
- Authority
- AT
- Austria
- Prior art keywords
- enantiomerically enriched
- oxyde
- producing enantiomerically
- enriched tetrahydrobenzothiepine
- tetrahydrobenzothiepine
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- KZPHSSFCYARZCD-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1-benzothiepine Chemical compound S1CCCCC2=CC=CC=C21 KZPHSSFCYARZCD-UHFFFAOYSA-N 0.000 title 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6817097P | 1997-12-19 | 1997-12-19 | |
| PCT/US1998/026216 WO1999032478A1 (en) | 1997-12-19 | 1998-12-16 | Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234829T1 true ATE234829T1 (de) | 2003-04-15 |
Family
ID=22080853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98962044T ATE234829T1 (de) | 1997-12-19 | 1998-12-16 | Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6369220B1 (de) |
| EP (1) | EP1042314B1 (de) |
| JP (1) | JP2001526284A (de) |
| KR (1) | KR20010015884A (de) |
| CN (2) | CN1106395C (de) |
| AT (1) | ATE234829T1 (de) |
| AU (1) | AU1721399A (de) |
| BR (1) | BR9814300A (de) |
| DE (1) | DE69812419T2 (de) |
| DK (1) | DK1042314T3 (de) |
| ES (1) | ES2195428T3 (de) |
| HU (1) | HUP0101193A3 (de) |
| IL (1) | IL136864A (de) |
| PT (1) | PT1042314E (de) |
| RU (1) | RU2236406C2 (de) |
| UA (1) | UA67764C2 (de) |
| WO (1) | WO1999032478A1 (de) |
| ZA (1) | ZA9811648B (de) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| WO2000038721A1 (en) | 1998-12-23 | 2000-07-06 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| HK1052183A1 (zh) * | 2000-03-10 | 2003-09-05 | Pharmacia Corporation | 制造tetrahydrobenzothiepines的方法 |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| MXPA04002179A (es) | 2001-09-08 | 2004-06-29 | Astrazeneca Ab | Derivados de benzotiazepina y benzotiadiazepina con actividad inhibidora de transporte del acido ileal biliar (ibat) para tratar hiperlipidemia. |
| JP2005518347A (ja) * | 2001-11-02 | 2005-06-23 | ジー．ディー． サール エルエルシー | 頂端ナトリウム共依存性胆汁酸輸送（ａｓｂｔ）およびタウロコール酸塩取り込みの阻害剤としての新規一および二フッ化ベンゾチエピン化合物 |
| BR0306643A (pt) | 2002-01-17 | 2004-10-19 | Pharmacia Corp | Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| CA2557576C (en) | 2004-02-27 | 2010-02-09 | Asahi Kasei Pharma Corporation | Novel benzothiazepine and benzothiepine compounds |
| EP2367554A4 (de) * | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von adipositas und diabetes |
| EP4137137A1 (de) | 2010-05-26 | 2023-02-22 | Satiogen Pharmaceuticals, Inc. | Gallensäurerecyclinghemmer und satiogene zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen |
| PL3400944T3 (pl) | 2010-11-04 | 2020-11-16 | Albireo Ab | Inhibitory ibat w leczeniu chorób wątroby |
| PT2637646T (pt) | 2010-11-08 | 2016-08-17 | Albireo Ab | Uma combinação farmacêutica que compreende um inibidor do ibat e um sequestrador de ácido biliar |
| CN102558250B (zh) * | 2010-12-14 | 2015-01-14 | 王芃 | 一种艾杜糖醛酸及其衍生物的制备方法 |
| SG10201909122QA (en) | 2011-10-28 | 2019-11-28 | Lumena Pharmaceuticals Inc | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| US20140323412A1 (en) | 2011-10-28 | 2014-10-30 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease |
| US10012627B2 (en) | 2013-03-15 | 2018-07-03 | Georgetown University | Determining stereoisomeric excess, concentration and absolute configuration |
| CA2907230A1 (en) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease |
| CA2907214A1 (en) | 2013-03-15 | 2014-09-18 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux disease |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| KR102560954B1 (ko) | 2014-06-25 | 2023-07-31 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
| EP3012252A1 (de) | 2014-10-24 | 2016-04-27 | Ferring BV | Kristalline Form von elobixibat |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| ES2874669T3 (es) | 2016-02-09 | 2021-11-05 | Albireo Ab | Formulación oral de colestiramina y uso de la misma |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| CN108601745B (zh) | 2016-02-09 | 2021-12-07 | 阿尔比里奥公司 | 口服考来烯胺制剂及其用途 |
| CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
| WO2019032027A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE |
| EP3802504B1 (de) | 2018-06-05 | 2023-01-18 | Albireo AB | Benzothia(di)azepinverbindungen und ihre verwendung als gallensäuremodulatoren |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| EP3810084A1 (de) | 2018-06-20 | 2021-04-28 | Albireo AB | Pharmazeutische formulierung von odevixibat |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US12486293B2 (en) | 2018-07-30 | 2025-12-02 | Georgetown University | Chirality sensing with molecular click chemistry probes |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11860084B2 (en) | 2018-09-11 | 2024-01-02 | Georgetown University | Quantitative auxiliary-free chirality sensing with a metal probe |
| CN109516971B (zh) * | 2018-11-26 | 2020-09-25 | 山东永浩新材料科技有限公司 | 一种电池级硫酸乙烯酯的合成方法 |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| DK3921028T3 (da) | 2019-02-06 | 2023-01-23 | Albireo Ab | Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| JP7562546B2 (ja) | 2019-02-12 | 2024-10-07 | ミルム ファーマシューティカルズ インコーポレイテッド | 胆汁うっ滞性肝疾患を有する小児対象の成長を増加させる方法 |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| JP7696897B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| ES2972045T3 (es) | 2019-12-04 | 2024-06-10 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
| CN114761018B (zh) | 2019-12-04 | 2025-12-02 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| DK4069360T3 (da) | 2019-12-04 | 2024-02-26 | Albireo Ab | Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer |
| CN116157389B (zh) | 2020-08-03 | 2026-02-10 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| JP2023549226A (ja) | 2020-11-12 | 2023-11-22 | アルビレオ エービー | 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット |
| WO2022117778A1 (en) | 2020-12-04 | 2022-06-09 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
| PY2373529A (es) * | 2022-09-14 | 2024-03-25 | Mirum Pharmaceuticals Inc | Maralixibat formas sólidas, intermedios y procesos de hacer la misma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59144777A (ja) | 1983-02-04 | 1984-08-18 | Tokawa Tetsuo | ベンゾチアゼピン誘導体の光学分割法 |
| US5559017A (en) | 1989-08-09 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Microbial reduction of benzazepines and benzothiazepine derivatives |
| TW197435B (de) * | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
| IT1249318B (it) | 1991-05-23 | 1995-02-22 | Zambon Spa | Processo per la preparazione di benzotiazepine per ciclizzazione con acidi fosfonici |
| CN1084741C (zh) * | 1994-09-13 | 2002-05-15 | 孟山都公司 | 具有回肠胆汁酸转运和牛磺胆酸盐摄入抑制剂作用的新的苯并硫杂䓬 |
| US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| IL126038A0 (en) | 1996-03-11 | 1999-05-09 | Searle & Co | Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them |
-
1998
- 1998-12-16 AU AU17213/99A patent/AU1721399A/en not_active Abandoned
- 1998-12-16 JP JP2000525415A patent/JP2001526284A/ja active Pending
- 1998-12-16 BR BR9814300-0A patent/BR9814300A/pt not_active IP Right Cessation
- 1998-12-16 KR KR1020007006795A patent/KR20010015884A/ko not_active Ceased
- 1998-12-16 RU RU2000119611/04A patent/RU2236406C2/ru not_active IP Right Cessation
- 1998-12-16 UA UA2000074377A patent/UA67764C2/uk unknown
- 1998-12-16 PT PT98962044T patent/PT1042314E/pt unknown
- 1998-12-16 EP EP98962044A patent/EP1042314B1/de not_active Expired - Lifetime
- 1998-12-16 US US09/581,897 patent/US6369220B1/en not_active Expired - Fee Related
- 1998-12-16 DK DK98962044T patent/DK1042314T3/da active
- 1998-12-16 DE DE69812419T patent/DE69812419T2/de not_active Expired - Fee Related
- 1998-12-16 ES ES98962044T patent/ES2195428T3/es not_active Expired - Lifetime
- 1998-12-16 AT AT98962044T patent/ATE234829T1/de not_active IP Right Cessation
- 1998-12-16 WO PCT/US1998/026216 patent/WO1999032478A1/en not_active Ceased
- 1998-12-16 HU HU0101193A patent/HUP0101193A3/hu unknown
- 1998-12-16 IL IL13686498A patent/IL136864A/en not_active IP Right Cessation
- 1998-12-16 CN CN98813609A patent/CN1106395C/zh not_active Expired - Fee Related
- 1998-12-18 ZA ZA9811648A patent/ZA9811648B/xx unknown
-
2002
- 2002-02-11 US US10/072,600 patent/US6875877B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 CN CN03107046A patent/CN1439638A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20020188119A1 (en) | 2002-12-12 |
| CN1106395C (zh) | 2003-04-23 |
| HUP0101193A2 (hu) | 2001-08-28 |
| PT1042314E (pt) | 2003-07-31 |
| JP2001526284A (ja) | 2001-12-18 |
| WO1999032478A1 (en) | 1999-07-01 |
| CN1439638A (zh) | 2003-09-03 |
| UA67764C2 (uk) | 2004-07-15 |
| DE69812419D1 (de) | 2003-04-24 |
| CN1284953A (zh) | 2001-02-21 |
| EP1042314B1 (de) | 2003-03-19 |
| DE69812419T2 (de) | 2003-08-14 |
| HUP0101193A3 (en) | 2001-12-28 |
| IL136864A (en) | 2004-07-25 |
| KR20010015884A (ko) | 2001-02-26 |
| IL136864A0 (en) | 2001-06-14 |
| BR9814300A (pt) | 2002-02-05 |
| ZA9811648B (en) | 1999-12-20 |
| AU1721399A (en) | 1999-07-12 |
| ES2195428T3 (es) | 2003-12-01 |
| HK1034971A1 (en) | 2001-11-09 |
| US6369220B1 (en) | 2002-04-09 |
| EP1042314A1 (de) | 2000-10-11 |
| DK1042314T3 (da) | 2003-07-14 |
| RU2236406C2 (ru) | 2004-09-20 |
| US6875877B2 (en) | 2005-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE234829T1 (de) | Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden | |
| DE69716767D1 (de) | Verfahren zur herstellung von tolterodin | |
| ATA271885A (de) | Verfahren zur herstellung von neuen aromatischen heterocyclischen verbindungen | |
| ATA100687A (de) | Verfahren zur herstellung von eisen | |
| DE3871346D1 (de) | Verfahren zur herstellung von nitrilen. | |
| DE3575949D1 (de) | Verfahren zur herstellung von vanadiumschlacke. | |
| AT387771B (de) | Verfahren zur herstellung von neuen oxazolidinen | |
| ATE218131T1 (de) | Verfahren zur herstellung von mono-n- substituierten tetraazamakrocyclen | |
| DE59805764D1 (de) | Verfahren zur selektiven Herstellung von racemischen ansa-Metallocenkomplexen | |
| DE3875008D1 (de) | Verfahren zur herstellung von nitrilen. | |
| ATA104285A (de) | Stereogesteuertes verfahren zur herstellung von neuen penem-verbindungen | |
| ATA41091A (de) | Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin | |
| DE3762238D1 (de) | Verfahren zur herstellung von n-substituierten formamiden. | |
| DE3765129D1 (de) | Verfahren zur herstellung von nitrilen. | |
| DE3774954D1 (de) | Verfahren zur herstellung von penemen. | |
| DE69502145D1 (de) | Verbessertes Verfahren zur Herstellung von Iodoniumsalzen | |
| AT387776B (de) | Verfahren zur herstellung von neuem 8alphapivaloylamino-9,10-didehydro-ergolin | |
| DE69729631D1 (de) | Verfahren zur herstellung von granisetron | |
| ATE182140T1 (de) | Optisch aktive 1,4-dihydropyridinderivate sowie verfahren zu ihrer herstellung | |
| ATA139685A (de) | Verfahren zur herstellung von neuen cephalosporinverbindungen | |
| DE69510227D1 (de) | Verfahren zur herstellung von fluorierten heterozyklischen verbindungen | |
| ATA278985A (de) | Verfahren zur herstellung von cephalosporinderivaten | |
| DE68916805D1 (de) | Verfahren zur herstellung von tocopherolen. | |
| DE68905073D1 (de) | Verfahren zur herstellung von racemischen cyclopropancarbonsaeurehalogeniden. | |
| DE3777236D1 (de) | Verfahren zur herstellung von 2-oxazolidinonen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1042314 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |